Heart Disease News and Research

Latest Heart Disease News and Research

FDA approves Santarus’ NDA for immediate-release prescription tablet product

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.

5 Dec 2009

Aetna Medicare Advantage members now have access to MidState Medical Center and Windham Hospital

Aetna (NYSE:ΑET) announced today that beginning January 1, 2010, its Medicare Advantage members will have access to MidState Medical Center and Windham Hospital as part of Aetna’s Medicare network of participating health care facilities in Connecticut.

5 Dec 2009

New findings shed light on heart attack symptoms

Researchers at Texas Health Presbyterian Hospital Dallas are investigating what symptoms could help doctors better spot heart attacks and if certain symptoms might indicate different types of heart attacks.

5 Dec 2009

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old.

4 Dec 2009

First patient treated in Carticept Medical's Cartiva SCI study

Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that the first patient has been treated in an international, multi-center study of the Company's Cartiva Synthetic Cartilage Implant (SCI). The study aims to determine the effectiveness of Cartiva SCI in comparison to arthrodesis (joint fusion), the current standard of care, for reducing the debilitating pain associated with osteoarthritis of the first metatarsophalangeal (MTP) joint.

4 Dec 2009

Senate bill moves forward, amendment ensures coverage for women's preventive care

Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."

4 Dec 2009

Health Policy Research Roundup

UCLA Center For Health Policy Research: Health Disparities Among California's Nearly Four Million Low-Income Nonelderly Adult Women - Using data from the 2007 California Health Interview Survey, the authors of this policy brief compare low-income women, ages 18-64, to others. The report finds the low-income women are four times more likely to report fair or poor health and are more likely to report a health condition that interferes with basic physical activities, such as walking or climbing stairs.

4 Dec 2009

Absorption Systems opens renovated AAALAC-accredited GLP surgical suite for medical device testing

Absorption Systems, a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today introduced an extensively renovated surgical suite for preclinical medical device testing at the company’s facility in San Diego, CA. Absorption Systems has long been recognized as a leader in drug testing and is experiencing increased demand for its medical device testing services as well.

4 Dec 2009

Axsun Technologies reports successful testing of novel OCT imaging integrated light source architecture

Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation, today announced the initial development and successful testing of a novel integrated light source architecture for OCT imaging. Axsun believes this proprietary optical engine design raises the bar on imaging speed and overcomes fundamental limitations of laser-based designs for swept source OCT light sources.

4 Dec 2009

Results from Phase III pivotal study of FIRMAGON presented

Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurrence rate in a Phase III pivotal study of FIRMAGON® (monthly degarelix for injection) or monthly leuprolide in prostate cancer patients during the first year of treatment.

4 Dec 2009

Stentys commences enrollment in its comparative stent study

Medical device pioneer Stentys announced today that the first patient has been enrolled into the ‘APPOSITION II’ clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in AMI patients. The primary endpoint of the ‘APPOSITION II’ study is stent strut apposition at day three post-procedure via extremely high-resolution OCT (optical coherence tomography) imaging.

4 Dec 2009

Pfizer to present study findings from its expanded breast cancer portfolio

Pfizer Oncology announced today that it will be presenting study findings evaluating several compounds including those from its newly expanded breast cancer portfolio following the recent acquisition of Wyeth, focusing on the needs of multiple breast cancer patient populations at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) being held December 9 – 13.

4 Dec 2009

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy. Unveiled at the annual North American Neuromodulation Society meeting, the Penta lead is the first of its kind, featuring the smallest electrodes in the market arranged in five columns.

4 Dec 2009

Guardsman Scientific emerges as winner of New England Venture Summit Top Innovator award

Guardsman Scientific is pleased to announce that it has been selected as a winner of the annual New England Venture Summit Top Innovator award by youngStartup Ventures.

4 Dec 2009

Effective prevention of smoking among teenagers narrows racial disparity in lung cancer rates

Effective prevention of smoking among teenagers, particularly black teenagers, is narrowing the disparity in lung cancer rates between blacks and whites, according to a report published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. The December issue has a special focus on tobacco.

4 Dec 2009

Mitral valve repair by experienced surgeons improves the survival rate of patients

Superior surgical techniques used in centres such as the University of Ottawa Heart Institute (UOHI) to fix a faulty heart valve flap, eliminate severe blood leakage and other serious cardiac conditions are highlighted as an expert guide to physicians and featured today in one of medicine's most prestigious journals.

4 Dec 2009

Type 2 diabetics with CAD experience greater antiplatelet activity with prasugrel compared to clopidogrel

Results from a new study showed patients with type 2 diabetes who also had coronary artery disease (CAD) experienced greater antiplatelet activity with the investigational antiplatelet drug prasugrel compared to Plavix(R) (clopidogrel). Patients who received a 60 mg loading dose and 10 mg maintenance dose of prasugrel achieved significantly greater platelet inhibition compared with a 600 mg loading dose and 150 mg maintenance dose of Plavix.

4 Dec 2009

GetWellNetwork experiences positive momentum for its IPC solutions across major hospitals

GetWellNetwork, Inc., the leading provider of Interactive Patient Care (IPC) solutions, today announced that major hospitals and healthcare providers selected its award-winning IPC solutions to improve patient engagement and quality. Additionally, hospitals already using GetWellNetwork's IPC solutions chose to expand and renew their projects to continue reaping performance improvements and affecting positive outcomes for their patients.

4 Dec 2009

New SPC3649 drug found effective in treating HCV infections

In a dramatic finding, a new drug for hepatitis C virus (HCV) infections that targets liver cells produced a substantial drop in blood levels of the virus in animals and continued to work up to several months after treatment, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.

4 Dec 2009

Weight loss - an effective treatment for sleep apnoea in obese men

For obese men, a dramatic weight loss can be an effective way to improve moderate to severe sleep apnoea, scientists at the Swedish medical university Karolinska Institutet report. Those with severe sleep apnoea when the study began benefited most from weight loss.

4 Dec 2009

Heart Disease News and Research

Latest Heart Disease News and Research

FDA approves Santarus’ NDA for immediate-release prescription tablet product

Aetna Medicare Advantage members now have access to MidState Medical Center and Windham Hospital

New findings shed light on heart attack symptoms

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

First patient treated in Carticept Medical's Cartiva SCI study

Senate bill moves forward, amendment ensures coverage for women's preventive care

Health Policy Research Roundup

Absorption Systems opens renovated AAALAC-accredited GLP surgical suite for medical device testing

Axsun Technologies reports successful testing of novel OCT imaging integrated light source architecture

Results from Phase III pivotal study of FIRMAGON presented

Stentys commences enrollment in its comparative stent study

Pfizer to present study findings from its expanded breast cancer portfolio

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

Guardsman Scientific emerges as winner of New England Venture Summit Top Innovator award

Effective prevention of smoking among teenagers narrows racial disparity in lung cancer rates

Mitral valve repair by experienced surgeons improves the survival rate of patients

Type 2 diabetics with CAD experience greater antiplatelet activity with prasugrel compared to clopidogrel

GetWellNetwork experiences positive momentum for its IPC solutions across major hospitals

New SPC3649 drug found effective in treating HCV infections

Weight loss - an effective treatment for sleep apnoea in obese men

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in